Creganna Medical:企業の戦略的SWOT分析

◆英語タイトル:Creganna Medical - Strategic SWOT Analysis Review
◆商品コード:SWOT20MY2797
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アイルランド
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥14,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥28,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥42,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Creganna Medical – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Creganna Medical (Creganna), a subsidiary of TE Connectivity Ltd, formerly known as Creganna-Tactx Medical, is a provider of medical device outsourcing solutions. The company is. It undertakes the design, development and commercialization of minimally invasive delivery and access devices for various therapies. The company’s products and services include design services, clinical and regulatory support, pilot manufacturing, volume manufacturing, manufacturing transfers and supply chain solutions. Its technologies include metal shafts, braided shafts, wire and coil, medical balloons, extrusion, molding and specialty needles. Creganna offers its products and services to medical device and life science companies. The company has presence in Ireland, the US, Singapore, China and Korea. Creganna is headquartered in Galway, Ireland.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Creganna Medical – Key Facts
Creganna Medical – Key Employees
Creganna Medical – Key Employee Biographies
Creganna Medical – Major Products and Services
Creganna Medical – History
Creganna Medical – Company Statement
Creganna Medical – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Creganna Medical – Business Description
Creganna Medical – SWOT Analysis
SWOT Analysis – Overview
Creganna Medical – Strengths
Creganna Medical – Weaknesses
Creganna Medical – Opportunities
Creganna Medical – Threats
Creganna Medical – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Creganna Medical, Medical Equipment, Deals By Year, 2014 to YTD 2020
Creganna Medical, Medical Equipment, Deals By Type, 2014 to YTD 2020
Creganna Medical, Recent Deals Summary
Section 4 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Creganna Medical, Key Facts
Creganna Medical, Key Employees
Creganna Medical, Key Employee Biographies
Creganna Medical, Major Products and Services
Creganna Medical, History
Creganna Medical, Other Locations
Creganna Medical, Subsidiaries
Creganna Medical, Key Competitors
Creganna Medical, Medical Equipment, Deals By Year, 2014 to YTD 2020
Creganna Medical, Medical Equipment, Deals By Type, 2014 to YTD 2020
Creganna Medical, Recent Deals Summary

List of Figures
Creganna Medical, Medical Equipment, Deals By Year, 2014 to YTD 2020
Creganna Medical, Medical Equipment, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Creganna Medical:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Centre for Drug Design and Discovery-製薬・医療分野:企業M&A・提携分析
    Summary Centre for Drug Design and Discovery (CD3) is a biomedical research institution that discovers new small molecule drugs. The institution provides services such as silico molecule design, modelling and screening, medicinal chemistry, intellectual property rights support, business development, …
  • ALTANA AG:企業のM&A・事業提携・投資動向
    ALTANA AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ALTANA AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • SeaBird Exploration PLC (SBX)-石油・ガス分野:企業M&A・提携分析
    Summary SeaBird Exploration Ltd (SeaBird) is an oil and gas company that provides marine 2D and 3D seismic data services. The company’s services include 2D seismic acquisition, 3D and 3D shallow water acquisition and source vessel. Its source vessels offers services such as conventional undershoots, …
  • La Jolla Institute for Allergy & Immunology:製薬・医療:M&Aディール及び事業提携情報
    Summary La Jolla Institute for Allergy & Immunology (LIAI) is a biomedical research institute that offers solutions for infectious agents and cancers. The institute provides research on prevention, treatment, and cure of immune system diseases. Its activities include disease research on allergy and …
  • University of Florida-製薬・医療分野:企業M&A・提携分析
    Summary University of Florida (UF) is an educational institute that offers undergraduate, graduate and distance learning programs. The institute offers educational programs in areas of agricultural, business administration, journalism and communications, law, dentistry, arts and sciences, medicine, …
  • Washington University in St Louis-医療機器分野:企業M&A・提携分析
    Summary Washington University in St Louis (Washington University), a subsidiary of University of Washington is an educational university which provides education and research services. The university provides various courses of bachelor’s, master’s, and doctoral degrees in a wide range of traditiona …
  • TTEC Holdings Inc (TTEC):企業の財務・戦略的SWOT分析
    TTEC Holdings Inc (TTEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • United States Postal Service:企業の戦略的SWOT分析
    United States Postal Service - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • V.F. Corporation (VFC):企業の財務・戦略的SWOT分析
    V.F. Corporation (VFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Amatsigroup SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Amatsigroup SAS (Amatsigroup) is a contract development manufacturing organization that offers human and veterinary pharmaceutical development through preclinical and clinical phases. The organization provides services such as bioservices, clinical trial supply, formulation development and m …
  • EnBW Energie Baden-Wurttemberg AG (EBK)-エネルギー分野:企業M&A・提携分析
    Summary EnBW Energie Baden-Wuerttemberg AG (EnBW) is an integrated energy holding company that generates, procures, transmits and supplies electricity; and produces, transports and supplies gas through its subsidiaries. Its generation portfolio includes nuclear, coal, oil, gas, wind, and pumped stor …
  • TheraVida Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary TheraVida Inc (TheraVida) is a clinical stage specialty pharmaceutical company focused on the development of new therapies for the treatment of primary focal hyperhidrosis. The company’s lead candidate THVD-102 is an oral acting drug used for the treatment of primary and secondary focal hype …
  • Ignyta Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Ignyta Inc (Ignyta), formerly NexDx Inc, a subsidiary of F. Hoffmann-La Roche Ltd, is a cancer care service provider. The company discovers, develops and commercializes new drugs targeting activated genes in cancer cells. It develops products using integrated therapeutic technology (Rx/Dx). …
  • Obton AS-エネルギー分野:企業M&A・提携分析
    Summary Obton A/S (Obton) is an investment company that specializes in management of assets within renewable energy. The company's investment process include screening process which inludes verification of prerequisites such as financial terms, amount of irradiation, power purchase agreement and fee …
  • Staatsolie Maatschappij Suriname NV:企業の戦略的SWOT分析
    Staatsolie Maatschappij Suriname NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • FUJIFILM Medical Systems USA Inc:企業の戦略的SWOT分析
    FUJIFILM Medical Systems USA Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Endologix Inc (ELGX):医療機器:M&Aディール及び事業提携情報
    Summary Endologix, Inc. (Endologix) is a medical device company. It undertakes the development, manufacturing and selling of minimally invasive treatments for aortic diseases. The company lays focus on its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). The company’s AAA p …
  • Cell C (Pty) Ltd.:企業の戦略・SWOT・財務情報
    Cell C (Pty) Ltd. - Strategy, SWOT and Corporate Finance Report Summary Cell C (Pty) Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • MEI Pharma Inc (MEIP)-製薬・医療分野:企業M&A・提携分析
    Summary MEI Pharma Inc (MEI), formerly Marshall Edwards Inc is an oncology company that offers clinical development of novel therapies for cancer. The company’s drug candidates comprise pracinostat, an oral HDAC inhibitor which is intended for the treatment of acute myeloid leukemia, myelodysplastic …
  • Bharat Heavy Electricals Ltd (BHEL):電力:M&Aディール及び事業提携情報
    Summary Bharat Heavy Electricals Limited (BHEL) is an integrated power plant equipment manufacturer that designs, manufactures, constructs, tests, commissions and services a broad range of products. Its product portfolio includes transformers, valves and oil field equipment, electrostatic precipitat …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆